PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management

ConclusionsDespite the clear superiority of PSMA PET over conventional imaging for primary staging of intermediate- and high-risk PCa, PSMA PET is currently not yet identified as the gold standard imaging modality in this setting in the European Association of Urology (EAU) guidelines, given that no prospective studies demonstrating a clear benefit of treatment adaptation are available at this moment. The results of prospective trials exploring the benefit of PSMA PET-based treatment algorithms are, therefore, strongly awaited.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research